Ultralife Corporation
ULBI
$4.13
-$0.15-3.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -1.56% | -9.61% | 0.68% | 31.37% | 23.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.56% | -9.61% | 0.68% | 31.37% | 23.38% |
| Cost of Revenue | 0.32% | -9.09% | -2.13% | 24.42% | 18.27% |
| Gross Profit | -7.04% | -11.17% | 9.21% | 54.25% | 41.10% |
| SG&A Expenses | 17.96% | 0.87% | 9.80% | 5.08% | -4.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.23% | -6.48% | 0.10% | 18.73% | 13.96% |
| Operating Income | -66.46% | -64.36% | 6.88% | 15,526.92% | 1,581.57% |
| Income Before Tax | -84.10% | -79.82% | -18.57% | 870.73% | 919.21% |
| Income Tax Expenses | -0.38% | -83.41% | -37.96% | 628.57% | 269.68% |
| Earnings from Continuing Operations | -91.82% | -78.59% | -10.60% | 966.87% | 1,366.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -269.57% | -177.78% | -200.00% | -18.18% | 2,200.00% |
| Net Income | -93.25% | -80.60% | -11.11% | 935.55% | 1,382.59% |
| EBIT | -66.46% | -64.36% | 6.88% | 15,526.92% | 1,581.57% |
| EBITDA | -47.93% | -43.79% | 6.04% | 404.61% | 267.14% |
| EPS Basic | -93.34% | -81.07% | -13.39% | 923.83% | 1,364.75% |
| Normalized Basic EPS | -88.76% | -68.99% | -21.27% | 827.13% | 517.69% |
| EPS Diluted | -93.70% | -80.63% | -13.39% | 923.83% | 941.00% |
| Normalized Diluted EPS | -88.83% | -69.29% | -22.48% | 821.81% | 514.29% |
| Average Basic Shares Outstanding | 1.78% | 2.38% | 2.65% | 1.62% | 1.26% |
| Average Diluted Shares Outstanding | 1.72% | 3.50% | 4.22% | 2.37% | 2.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |